Medicap Dandelion
Natural health product licensed in Canada
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80080252
- Status
- Active licence
- Licence date
- 27 September 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Taraxacum officinale Source : Plante entière Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 5,000 milligramme | 500 milligramme | Not calculated |
Non-medicinal ingredients
Éther stéaroxy hydroxypropyl méthylcellulose, Dioxyde de silicium, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as a diuretic. Traditionally used in Herbal Medicine to increase the amount of urine to achieve flushing of the urinary tract as an adjuvant in minor urinary complaints.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use this product.
- Précautions et mises en garde
If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80080252
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.